Colorectal cancer screening
- PMID: 7328198
- DOI: 10.1007/BF01323232
Colorectal cancer screening
Abstract
The efficacy of Hemoccult screening for colorectal carcinoma is analyzed utilizing five criteria which a screening test should fulfil before it is used for mass screening. The Hemoccult screening protocol has serious weaknesses. It is at best 83% sensitive for cancer and much less sensitive for polyps. An asymptomatic person with one or more positive Hemoccult slides only has a 12% chance of having cancer. In addition, patient acceptance of mass Hemoccult screening is questionable. There is currently little information on potential survival benefits, and Hemoccult screening is expensive with one quarter of all costs incurred in the diagnostic evaluation of false positives. There is insufficient evidence to recommend Hemoccult colorectal cancer screening in asymptomatic persons as a cost-effective practice.
Similar articles
-
Cost effectiveness of HemoQuant versus Hemoccult for colorectal cancer screening.J Gen Intern Med. 1988 Mar-Apr;3(2):132-8. doi: 10.1007/BF02596117. J Gen Intern Med. 1988. PMID: 3128650
-
Occult-blood screening for colorectal carcinoma: the yield and the costs.Am J Prev Med. 1985 Sep-Oct;1(5):18-24. Am J Prev Med. 1985. PMID: 3939711
-
Cost benefits of hemoccult screening for colorectal carcinoma.Dig Dis Sci. 1985 Sep;30(9):860-5. doi: 10.1007/BF01309517. Dig Dis Sci. 1985. PMID: 3928287
-
Fecal occult blood testing: clinical value and limitations.Gastroenterologist. 1998 Mar;6(1):66-78. Gastroenterologist. 1998. PMID: 9531118 Review.
-
Occult blood screening for colorectal carcinoma: a critical review.Gastroenterology. 1985 Mar;88(3):820-37. doi: 10.1016/0016-5085(85)90158-1. Gastroenterology. 1985. PMID: 3917961 Review.
Cited by
-
Cost effectiveness of HemoQuant versus Hemoccult for colorectal cancer screening.J Gen Intern Med. 1988 Mar-Apr;3(2):132-8. doi: 10.1007/BF02596117. J Gen Intern Med. 1988. PMID: 3128650
-
Assessing the cost-effectiveness of prevention.J Community Health. 1983 Winter;9(2):145-65. doi: 10.1007/BF01349877. J Community Health. 1983. PMID: 6430973
-
Routine hemoccult screening: the current evidence.Can Fam Physician. 1985 Jan;31:99-103. Can Fam Physician. 1985. PMID: 21279149 Free PMC article.
-
The pros and cons of fecal occult blood testing for colorectal neoplasms.Cancer Metastasis Rev. 1987;6(3):397-411. doi: 10.1007/BF00144272. Cancer Metastasis Rev. 1987. PMID: 3319274 Review.